IDbyDNA
IDbyDNA Nabs Additional Funding for Gene Editing Dx, Biosurveillance Tech
In collaboration with other firms, IDbyDNA is using precision metagenomics to develop a next-generation device for diagnostic testing of emerging infectious diseases.
DARPA Awards $36.7M to Six Organizations for Gene Editing-Based Dx, Biosurveillance Tech
The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.
CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.